Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
LEPORE DAWN G
   2. Issuer Name and Ticker or Trading Symbol
EBAY INC [EBAY] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O DRUGSTORE.COM, INC., 411 108TH AVE NE, SUITE 1400		 3. Date of Earliest Transaction (Month/Day/Year)
10/25/2010
(Street)

BELLEVUE, WA 98004		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/25/2010   M   31,250 A $ 15.55 51,250 D  
Common Stock 10/25/2010   S   31,250 (1) D $ 27.8054 20,000 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $ 15.55 10/25/2010   M     31,250   (2) 05/25/2011 Common Stock 31,250 $ 0 0 D  
Deferred Stock Units $ 0               (3) 04/29/2019(3) Common Stock 6,678   6,678 D  
Deferred Stock Units $ 0               (3) 04/29/2020(3) Common Stock 4,537   4,537 D  
Deferred Stock Units $ 0               (3)   (3) Common Stock 3,771   3,771 D  
Non-Qualified Stock Option (right to buy) $ 13.7525               (2) 06/05/2012 Common Stock 80,000   80,000 D  
Non-Qualified Stock Option (right to buy) $ 16.47               (4) 04/29/2016 Common Stock 16,516   16,516 D  
Non-Qualified Stock Option (right to buy) $ 18.7969               (2) 12/17/2009 Common Stock 20,889   20,889 D  
Non-Qualified Stock Option (right to buy) $ 24.24               (4) 04/29/2017 Common Stock 14,492   14,492 D  
Non-Qualified Stock Option (right to buy) $ 25.78               (2) 06/26/2013 Common Stock 60,000   60,000 D  
Non-Qualified Stock Option (right to buy) $ 29.17               (4) 06/19/2015 Common Stock 10,120   10,120 D  
Non-Qualified Stock Option (right to buy) $ 30.51               (2) 06/13/2013 Common Stock 15,000   15,000 D  
Non-Qualified Stock Option (right to buy) $ 31.61               (2) 06/14/2014 Common Stock 15,000   15,000 D  
Non-Qualified Stock Option (right to buy) $ 34.44               (2) 06/23/2015 Common Stock 15,000   15,000 D  
Non-Qualified Stock Option (right to buy) $ 44.37               (2) 06/24/2014 Common Stock 30,000   30,000 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
LEPORE DAWN G
C/O DRUGSTORE.COM, INC.
411 108TH AVE NE, SUITE 1400
BELLEVUE, WA 98004		   X      

Signatures

 By: Brian Levey For: Dawn G. Lepore   10/26/2010
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
(2) Options become exercisable as to 25% on the one year anniversary date of the grant and 1/48th monthly thereafter.
(3) In connection with the reporting person's continuous service as a non-employee director of the Company, such reporting person has been granted an exempt award of Deferred Stock Units ("DSUs") at the time of the Company's annual meeting of stockholders. The number of DSUs granted represents the quotient of (A) $110,000 divided by (B) the Company's closing stock price on the date of grant. The DSUs becomes vested as to 25% on the one year anniversary of the grant and 1/48th monthly thereafter, provided that the reporting person continues as a director or consultant of the Company through such date.
(4) In connection with the reporting person's continuous service as a non-employee director of the Company, such reporting person has been granted options at the time of the Company's annual meeting of stockholders. The number of options granted is equal to the net present value of $110,000, calculated using the Black-Scholes valuation methodology on the date of grant. Options become exercisable as to 25% on the one year anniversary date of the grant and 1/48th monthly thereafter, provided that the reporting person continues as a director or consultant of the Company through such date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.